Shehnaaz Suliman
2017
In 2017, Shehnaaz Suliman earned a total compensation of $4.1M as Senior Vice President, Corporate Development and Strategy at Theravance Biopharma.
Compensation breakdown
| Bonus | $245,000 |
|---|---|
| Non-Equity Incentive Plan | $142,500 |
| Option Awards | $2,844,865 |
| Salary | $201,515 |
| Stock Awards | $638,600 |
| Other | $2,981 |
| Total | $4,075,461 |
Suliman received $2.8M in option awards, accounting for 70% of the total pay in 2017.
Suliman also received $245K in bonus, $142.5K in non-equity incentive plan, $201.5K in salary, $638.6K in stock awards and $3K in other compensation.
Rankings
In 2017, Shehnaaz Suliman's compensation ranked 2,512th out of 14,666 executives tracked by ExecPay. In other words, Suliman earned more than 82.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,512 out of 14,666 | 83rd |
Division Manufacturing | 875 out of 5,772 | 85th |
Major group Chemicals And Allied Products | 232 out of 2,075 | 89th |
Industry group Drugs | 178 out of 1,731 | 90th |
Industry Pharmaceutical Preparations | 143 out of 1,333 | 89th |
Source: SEC filing on March 21, 2018.
Suliman's colleagues
We found four more compensation records of executives who worked with Shehnaaz Suliman at Theravance Biopharma in 2017.